Unlocking Novel T Cell-Based Immunotherapy for Hepatocellular Carcinoma through Neoantigen-Driven T Cell Receptor Isolation

Investigators evaluated T cell responses in patients with advanced hepatocellular carcinoma by analysing tumours, liver flushes and liver-draining lymph nodes, to understand whether reactive T cell populations could be identified despite the immunosuppressive environment.